{
    "answer": "Full year 2024 net sales: USD 50.3 billion (+11%, +12% cc). Cosentyx's net sales for Q4 2024: USD 1596 million (+22%, +24% cc). Immunology segment sales for 2024 (specifically, Cosentyx's): Not available in the supplementary financial data provided.",
    "ground_truth": "$6,141,000,000; 23% increase (reported); 25% increase (constant currency)",
    "rewards": [
        0,
        0,
        0,
        0,
        0
    ],
    "reward_sum": 0,
    "turns": 5,
    "search count": 4,
    "script count": 0,
    "summary count": 0,
    "context lengths": [
        875,
        2476,
        3009,
        3374,
        4963
    ]
}